Fidelity Investments’s ImageneBio Inc IMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-67
Closed -$546 5495
2025
Q3
$546 Buy
+67
New +$888 ﹤0.01% 5078
2025
Q2
Sell
-422
Closed -$6.48K 5411
2025
Q1
$6.48K Sell
422
-460
-52% -$7.93K ﹤0.01% 4628
2024
Q4
$17.4K Sell
882
-2,316
-72% -$46.8K ﹤0.01% 4241
2024
Q3
$66.4K Buy
3,198
+1,551
+94% +$31.4K ﹤0.01% 3667
2024
Q2
$32.6K Buy
1,647
+1,164
+241% +$20.6K ﹤0.01% 3832
2024
Q1
$8.24K Sell
483
-348,208
-100% -$6.34M ﹤0.01% 4346
2023
Q4
$8.24M Sell
348,691
-22,820
-6% -$744K ﹤0.01% 1912
2023
Q3
$19.3M Sell
371,511
-51,058
-12% -$3.07M ﹤0.01% 1594
2023
Q2
$33.3M Buy
422,569
+146,454
+53% +$10.5M ﹤0.01% 1428
2023
Q1
$11.4M Sell
276,115
-34,266
-11% -$1.57M ﹤0.01% 1822
2022
Q4
$9.91M Buy
310,381
+99,864
+47% +$3.19M ﹤0.01% 1894
2022
Q3
$8.97M Sell
210,517
-155,793
-43% -$9.01M ﹤0.01% 1947
2022
Q2
$19.5M Sell
366,310
-22,395
-6% -$1.24M ﹤0.01% 1657
2022
Q1
$28.5M Sell
388,705
-4,936
-1% -$525K ﹤0.01% 1627
2021
Q4
$59.2M Sell
393,641
-25,621
-6% -$4.16M ﹤0.01% 1357
2021
Q3
$63.5M Buy
419,262
+49,957
+14% +$7.26M 0.01% 1315
2021
Q2
$60.5M Buy
369,305
+54,502
+17% +$12M ﹤0.01% 1348
2021
Q1
$99.7M Buy
+314,803
New +$108M 0.01% 1067

Other funds holding IMA

Fidelity Investments's IMA Position: Q4 2025 in Review

Fidelity Investments sold out of ImageneBio Inc (IMA) in Q4 2025, closing a stake of 67 shares — an estimated $546 sold.

Fidelity Investments first reported a position in IMA in Q1 2021 and held it in 18 quarters. The position peaked at $99.7M in Q1 2021. 41 funds tracked by Wall St. Rank hold IMA as of Q4 2025.

  • Fidelity Investments reported no remaining ImageneBio Inc position as of Q4 2025 after selling out during the quarter.
  • Fidelity Investments sold 67 ImageneBio Inc shares in Q4 2025, an estimated $546.
  • Fidelity Investments first reported a position in ImageneBio Inc in Q1 2021 and held it in 18 quarters.
  • Fidelity Investments's ImageneBio Inc position peaked at $99.7M in Q1 2021.
  • 41 funds tracked by Wall St. Rank held ImageneBio Inc as of Q4 2025.

Based on Fidelity Investments's 13F filing for Q4 2025, filed 17 Feb 2026.